These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15468716)

  • 21. Evolution of pulmonary hypertension in chronic respiratory diseases.
    Weitzenblum E; Jezek V
    Bull Eur Physiopathol Respir; 1984; 20(1):73-81. PubMed ID: 6704569
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical study of patients with pulmonary hypertension due to chronic obstructive lung disease (author's transl)].
    Nakashima A; Shiigi T; Arima A; Sada K; Moriyama K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Sep; 15(9):615-20. PubMed ID: 592576
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hypoxic pulmonary hypertension: nifedipine therapy].
    Agostoni P; Doria E; Galli C; Tamborini G; Fiorentini C; Guazzi M
    Cardiologia; 1988 Oct; 33(10):961-9. PubMed ID: 3233606
    [No Abstract]   [Full Text] [Related]  

  • 24. [Physiopathology of pulmonary hypertension in chronic obstructive lung diseases].
    Mitre N; Kasinski N; Romaldini H
    Arq Bras Cardiol; 1987 Jan; 48(1):61-5. PubMed ID: 3662895
    [No Abstract]   [Full Text] [Related]  

  • 25. Pulmonary hypertension in human newborns with congenital diaphragmatic hernia is associated with decreased vascular expression of nitric-oxide synthase.
    Shehata SM; Sharma HS; Mooi WJ; Tibboel D
    Cell Biochem Biophys; 2006; 44(1):147-55. PubMed ID: 16456243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Course of pulmonary hemodynamics in intermittent ventilation].
    Herth F; Schulz MR; Schulz V
    Pneumologie; 1999 Oct; 53 Suppl 2():S120-1. PubMed ID: 10613061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypoxia and inflammation--causes of acute and chronic pulmonary artery hypertension].
    Ziesche R
    Pneumologie; 1997 May; 51(5):495-8. PubMed ID: 9265151
    [No Abstract]   [Full Text] [Related]  

  • 28. Myocardial function in chronic pulmonary diseases. The myocardial function in primary hypertension and in chronic obstructive lung disease.
    Degenring FH
    Bull Physiopathol Respir (Nancy); 1972; 8(6):1456-9. PubMed ID: 4267074
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical study of pulmonary hypertension in chronic obstructive pulmonary disease].
    Mitre N; Romaldini H; Kasinski N; Ferreira C; Paola AA; Martinez Filho EE
    Arq Bras Cardiol; 1988 Feb; 50(2):79-85. PubMed ID: 3214319
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pathogenetic mechanisms and the the clinical aspects of secondary pulmonary hypertension and respiratory system diseases].
    Carratu' L; Marangio E; Cuomo A; Pesci A
    Torace; 1979 Mar; 22(1):50-71. PubMed ID: 400054
    [No Abstract]   [Full Text] [Related]  

  • 31. Pulmonary hypertension in COPD: old and new concepts.
    Barberà JA; Peinado VI; Santos S
    Monaldi Arch Chest Dis; 2000 Dec; 55(6):445-9. PubMed ID: 11272628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression of flow-induced pulmonary arterial vasculopathy after flow correction in piglets.
    Mercier O; Sage E; de Perrot M; Tu L; Marcos E; Decante B; Baudet B; Hervé P; Dartevelle P; Eddahibi S; Fadel E
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1538-46. PubMed ID: 19464477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
    Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Obstructive respiratory tract diseases and pulmonary micro circulation].
    Schulz V
    Prax Klin Pneumol; 1980 Jun; 34(6):332-7. PubMed ID: 7422617
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular-pulmonary interaction in chronic obstructive pulmonary disease with special reference to the pathogenesis and management of cor pulmonale.
    Matthay RA; Niederman MS; Wiedemann HP
    Med Clin North Am; 1990 May; 74(3):571-618. PubMed ID: 2186234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Systemic arterial hypertension in chronic lung diseases].
    Kubyshkin VF; Soldatchenko SS
    Ter Arkh; 1982; 54(2):90-5. PubMed ID: 6918177
    [No Abstract]   [Full Text] [Related]  

  • 37. Defective lung vascular development in endothelial nitric oxide synthase-deficient mice.
    Han RN; Stewart DJ
    Trends Cardiovasc Med; 2006 Jan; 16(1):29-34. PubMed ID: 16387628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-invasive evaluation of pulmonary artery pressure in chronic obstructive lung diseases--with special reference to prediction of the pulmonary artery pressure using multiple regression analysis].
    Miyamoto K; Irie T; Kawakami Y; Murao M
    Kokyu To Junkan; 1983 Feb; 31(2):173-9. PubMed ID: 6867482
    [No Abstract]   [Full Text] [Related]  

  • 39. [Relation of the plasma level of atrial natriuretic peptide and hemodynamic parameters in patients with chronic obstructive pulmonary disease].
    Wang T
    Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):148-50. PubMed ID: 2163741
    [No Abstract]   [Full Text] [Related]  

  • 40. Pulmonary hemodynamics in symptomatic coal miners.
    Lapp NL; Seaton A; Kaplan KC; Hunsaker MR; Morgan WK
    Am Rev Respir Dis; 1971 Sep; 104(3):418-26. PubMed ID: 5098674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.